Insomnia in Older Adults: Why Sleep Changes With Age

How Sleep Architecture Changes With Aging

As you age, sleep does not simply get shorter — its architecture fundamentally shifts. The proportions of sleep stages change across the lifespan.

The most significant change is a reduction in slow-wave sleep (N3, deep sleep). Research published in PMC (PMC5841578) documents that the percentage of N3 sleep decreases linearly at approximately 2% per decade up to age 60. More striking is the intensity of slow-wave activity (SWA): maximal age-related decrements over prefrontal cortex regions average 75–80% compared to young adults. (PMC4857208)

At the same time, lighter sleep stages (N1, N2) increase and nocturnal awakenings become more frequent. The result is sleep that occurs but is shallower and more fragmented — less effective for physical restoration and memory consolidation.

Circadian rhythms also weaken. Nocturnal peak melatonin secretion tends to decline significantly after age 60 (PMC9842516), and the sleep-wake timing advances — producing early evening sleepiness and early morning awakening. This is called circadian phase advance. For a deeper dive into sleep stages, see the complete guide to sleep stages.

Common Causes of Insomnia in Older Adults

Approximately 30–48% of adults over 65 report insomnia symptoms, with 12–20% meeting criteria for diagnosed insomnia disorder. (PMC5847293) These rates are elevated not because of aging itself, but because of factors that accumulate alongside it.

• Chronic pain. Arthritis, back pain, and neuropathic pain make it difficult to stay asleep. Pain and insomnia have a bidirectional relationship — each worsens the other.
• Polypharmacy. Older adults take an average of five or more medications. Beta-blockers, corticosteroids, some antidepressants, diuretics, and decongestants can all disrupt sleep. Learn more about medication-induced insomnia.
• Nocturia. Approximately 30% of adults aged 60–69 and 40% aged 70 and older experience nocturia. Among adults aged 55–84, 53% report that nocturia disrupts sleep almost every night — four times the proportion reporting pain as the cause. (PMC4713267)
• Mental health conditions. Depression and anxiety are prevalent in older adults and show high comorbidity with insomnia. Both need to be addressed independently.
• Sleep-disordered breathing. Sleep apnea is more prevalent in older adults and can cause insomnia-like awakenings. Suspected snoring or breathing pauses warrant a sleep study.

The Insomnia–Kidney Disease Connection

For older adults with kidney disease, insomnia is a particularly serious concern. An estimated 50–75% of people with advanced chronic kidney disease (CKD) experience sleep disturbances, rising to approximately 80% among patients receiving dialysis for end-stage renal disease. (PMC9065912)

The causes are multilayered. Uremic symptoms (skin pruritus, restless legs syndrome), nocturia, metabolic imbalances, systemic inflammation, and medications used to manage CKD all disrupt sleep. CKD patients also have elevated rates of depression and chronic pain, compounding insomnia risk factors.

Restless legs syndrome (RLS) occurs in CKD patients at 3–4 times the rate seen in the general population. Iron deficiency and uremic toxins disrupting dopamine pathways are the primary mechanisms. If RLS is suspected, asking your doctor about iron levels and dopamine agonist options is worthwhile.

Why Sleeping Pills Are Risky for Older Adults

Sleeping pills do not work the same way in older adults as in younger people. Age-related slowing of drug metabolism, changes in body fat ratio, and reduced kidney and liver function mean that benzodiazepines and Z-drugs (zolpidem, eszopiclone, etc.) linger in the older adult's system far longer.

The 2023 AGS Beers Criteria officially designated benzodiazepines and nonbenzodiazepine sedative-hypnotics (Z-drugs) as medications to avoid in older adults with a history of falls or fractures. The core risks are:

• Falls and fractures. Sedative-hypnotic users face approximately 30% higher fracture risk than non-users. (PMC12645778) Residual sedation impairs balance and reaction time during nighttime bathroom trips.
• Cognitive impairment. Long-term benzodiazepine use is associated with memory deficits and attention difficulties, with ongoing research into possible links to elevated dementia risk.
• Next-day residual drowsiness. Long-acting agents (especially long-acting benzodiazepines) can cause drowsiness well into the next morning, contributing to falls and driving impairment.
• Rebound insomnia. Stopping the medication often causes insomnia worse than before treatment. This creates a cycle that reinforces dependence.

The Mayo Clinic explicitly states that sleeping pills are not a long-term solution for chronic insomnia, and cautions that even short-term use requires care in older adults. Melatonin has a better safety profile than benzodiazepines but produces modest effect sizes. For a detailed look at melatonin, see the melatonin sleep guide.

Evidence-Based Alternatives to Sleeping Pills

There is good news: treatments exist for insomnia in older adults that are more durable and safer than medication. The cornerstone is CBT-I (Cognitive Behavioral Therapy for Insomnia).

CBT-I: First-Line Treatment That Works in Older Adults

The AASM recommends CBT-I before medication for chronic insomnia — and this applies equally to older adults. A 2024 study (PMID 38888493) demonstrated that CBT-I significantly improved insomnia severity, sleep quality, fatigue, and daytime sleepiness in older veterans with chronic pain. Importantly, pain did not meaningfully hinder CBT-I's effects. For a deep dive into CBT-I, see the complete CBT-I guide.

The core components of CBT-I — sleep restriction therapy, stimulus control, cognitive restructuring, relaxation techniques, and sleep hygiene — work together to reset the brain's association between bed and sleep.

Light Therapy

Given the weakening of circadian rhythms and declining melatonin in older adults, bright light exposure is a theoretically well-grounded approach. Research (PMC2743069) indicates morning bright light exposure can help correct advanced sleep phase patterns. Note that evidence for light therapy in non-circadian insomnia is modest (g = 0.47), making it most appropriate when circadian disruption is a component. (PMC3839957)

Sleep Hygiene Optimization

Sleep hygiene alone cannot resolve chronic insomnia, but it is an important foundation that supports CBT-I. For older adults specifically, limiting naps to under 20 minutes and reducing fluid intake after 7 PM to minimize nocturia are particularly relevant. See the full sleep hygiene checklist.

When to See a Doctor About Sleep

The National Institute on Aging recommends talking to a doctor about sleep problems at any age. The following situations warrant prompt evaluation:

• Difficulty falling asleep, staying asleep, or waking too early at least 3 nights per week for 3 or more months
• Daytime fatigue, difficulty concentrating, mood changes, or memory problems attributable to poor sleep
• Loud snoring or witnessed breathing pauses during sleep (possible sleep apnea)
• Uncomfortable urge to move the legs at night (possible restless legs syndrome)
• Depressive symptoms, loss of appetite, or excessive anxiety occurring alongside insomnia
• Sleep problems that began after starting a new medication

Doctors typically begin evaluation with validated tools such as the Insomnia Severity Index (ISI) or the Pittsburgh Sleep Quality Index (PSQI), combined with a sleep diary. A referral to a sleep specialist for polysomnography may follow. The critical point: sleep problems should not be attributed to age and left untreated.

Understanding your own sleep patterns before an appointment can help. Try the insomnia self-assessment to get a clearer picture of your sleep before seeing a doctor.